Published in Medical Letter on the CDC and FDA, November 16th, 2003
"Our licensee has indicated to us that our file is in queue for receipt of the final signature. Responsible parties at the Board of Health have been out of Mexico; they have now returned. Our licensee's office is in regular contact with the Board of Health in Mexico City and the final required signature is expected shortly," Rieveley said.
"We project that our first order from Mexico will be in the range of one million Sucanon tablets. We are currently preparing for production of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.